Proteocyte AI ^Company

Proteocyte AI is a molecular diagnostics company based in Toronto, Canada. Their main goal is to reduce the incidence of cancer worldwide by developing lab tests that can predict the risk of developing cancer. They have developed a platform that combines specific protein biomarkers with proprietary algorithms, advanced imaging, and digital pathology to accurately predict the risk of cancer. With over 25 years of experience in the Canadian medical device industry, their sales and marketing leader, Todd, has successfully built and led high-performance teams and developed talent in the field of medical diagnostics.